Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Revenue (Gross) (2021 - 2025)

Abeona Therapeutics has reported Revenue (Gross) over the past 5 years, most recently at $1.5 million for Q4 2025.

  • Quarterly results put Revenue (Gross) at $1.5 million for Q4 2025, up 51.22% from a year ago — trailing twelve months through Dec 2025 was $5.6 million (up 30.85% YoY), and the annual figure for FY2025 was $5.6 million, up 30.85%.
  • Revenue (Gross) for Q4 2025 was $1.5 million at Abeona Therapeutics, down from $1.7 million in the prior quarter.
  • Over the last five years, Revenue (Gross) for ABEO hit a ceiling of $1.7 million in Q3 2025 and a floor of $5000.0 in Q4 2021.
  • Median Revenue (Gross) over the past 5 years was $668000.0 (2023), compared with a mean of $687166.7.
  • Biggest five-year swings in Revenue (Gross): surged 6460.0% in 2022 and later decreased 13.77% in 2025.
  • Abeona Therapeutics' Revenue (Gross) stood at $5000.0 in 2021, then surged by 6460.0% to $328000.0 in 2022, then soared by 126.52% to $743000.0 in 2023, then soared by 37.69% to $1.0 million in 2024, then soared by 51.22% to $1.5 million in 2025.
  • The last three reported values for Revenue (Gross) were $1.5 million (Q4 2025), $1.7 million (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.